---
title: "Elation Health wins Best in KLAS Award for 2026 in Small Practice Ambulatory EMR/PM for 1-10 physicians."
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/274831590.md"
description: "Elation Health, a leading technology company focusing on primary care, was recently recognized as the top solution for Small Practice Ambulatory EMR/PM for practices with 1–10 physicians in the 2026 Best in KLAS: Software and Services report. This acknowledgment was solely determined by customer feedback, highlighting Elation's appeal as a practical technology that enhances medical practice and reinforces physician-patient relationships."
datetime: "2026-02-04T14:22:30.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/274831590.md)
  - [en](https://longbridge.com/en/news/274831590.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/274831590.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/274831590.md) | [English](https://longbridge.com/en/news/274831590.md)


# Elation Health wins Best in KLAS Award for 2026 in Small Practice Ambulatory EMR/PM for 1-10 physicians.

Elation Health, a leading technology company focusing on primary care, was recently recognized as the top solution for Small Practice Ambulatory EMR/PM for practices with 1–10 physicians in the 2026 Best in KLAS: Software and Services report. This acknowledgment was solely determined by customer feedback, highlighting Elation's appeal as a practical technology that enhances medical practice and reinforces physician-patient relationships.

### 相關股票

- [iShares Biotechnology ETF (IBB.US)](https://longbridge.com/zh-HK/quote/IBB.US.md)
- [Proshares Ultra Nasdaq Biotech (BIB.US)](https://longbridge.com/zh-HK/quote/BIB.US.md)
- [ALPS Medical Breakthrough (SBIO.US)](https://longbridge.com/zh-HK/quote/SBIO.US.md)
- [Invesco Biotechnology & Genome ETF (PBE.US)](https://longbridge.com/zh-HK/quote/PBE.US.md)
- [First Trust NYSE Arca Biotech Index Fd (FBT.US)](https://longbridge.com/zh-HK/quote/FBT.US.md)
- [Health Care Select Sector SPDR (XLV.US)](https://longbridge.com/zh-HK/quote/XLV.US.md)
- [Elevance Health (ELV.US)](https://longbridge.com/zh-HK/quote/ELV.US.md)
- [Ark Genomic Revolution ETF (ARKG.US)](https://longbridge.com/zh-HK/quote/ARKG.US.md)
- [VanEck Biotech ETF (BBH.US)](https://longbridge.com/zh-HK/quote/BBH.US.md)
- [Invesco Nasdaq Biotechnology ETF (IBBQ.US)](https://longbridge.com/zh-HK/quote/IBBQ.US.md)
- [iShares US Healthcare Providers (IHF.US)](https://longbridge.com/zh-HK/quote/IHF.US.md)
- [iShares US Pharma (IHE.US)](https://longbridge.com/zh-HK/quote/IHE.US.md)
- [SPDR S&P Biotech (XBI.US)](https://longbridge.com/zh-HK/quote/XBI.US.md)
- [iShares Global Healthcare (IXJ.US)](https://longbridge.com/zh-HK/quote/IXJ.US.md)
- [VG Health (VHT.US)](https://longbridge.com/zh-HK/quote/VHT.US.md)

## 相關資訊與研究

- [BUZZ-Context Therapeutics rises as FDA grants fast-track status to ovarian cancer drug](https://longbridge.com/zh-HK/news/281517197.md)
- [Telomir seeks FDA approval for Telomir-1 to treat breast cancer](https://longbridge.com/zh-HK/news/281346305.md)
- [Telomir submits IND for Telomir-1 to treat advanced and metastatic TNBC](https://longbridge.com/zh-HK/news/281174396.md)
- [Regeneron Gets FDA OK for Extended Eylea HD Dosing](https://longbridge.com/zh-HK/news/281556416.md)
- [Iterum Therapeutics Received Notice of Delisting](https://longbridge.com/zh-HK/news/281174211.md)